Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

768 results about "Bacillus strain" patented technology

Bacillus subtilis is a robust strain that not only can withstand the gastrointestinal tract but also can positively affect the composition of the microbiota. It does this by forming endospores – durable protein envelopes that protect it from heat, light, and other stressors.

Probiotic, lactic acid-producing bacteria and uses thereof

InactiveUS7708988B2Good curative effectMitigating deleterious side-effectsAntibacterial agentsBiocideDiseaseMicrobial agent
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid-producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds. The present invention also discloses methodologies for: (i) the selective breeding and isolation of probiotic, lactic acid-producing bacterial strains which possess resistance or markedly decreased sensitivity to anti-microbial agents (e.g., antibiotics, anti-fungal agents, anti-yeast agents, and anti-viral agents); and (ii) treating or preventing bacteria-mediated infections of the gastrointestinal tract by use of the aforementioned probiotic bacterial strains with or without the concomitant administration of antibiotics. While the primary focus is on the treatment of gastrointestinal tract infections, the therapeutic compositions of the present invention may also be administered to buccal, vaginal, optic, and like physiological locations.
Owner:GANEDEN BIOTECH

Probiotic, lactic acid-producing bacteria and uses thereof

InactiveUS20080233104A1Good curative effectMitigating deleterious side-effectsAntibacterial agentsAntimycoticsDiseaseMicrobial agent
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid-producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds. The present invention also discloses methodologies for: (i) the selective breeding and isolation of probiotic, lactic acid-producing bacterial strains which possess resistance or markedly decreased sensitivity to anti-microbial agents (e.g., antibiotics, anti-fungal agents, anti-yeast agents, and anti-viral agents); and (ii) treating or preventing bacteria-mediated infections of the gastrointestinal tract by use of the aforementioned probiotic bacterial strains with or without the concomitant administration of antibiotics. While the primary focus is on the treatment of gastrointestinal tract infections, the therapeutic compositions of the present invention may also be administered to buccal, vaginal, optic, and like physiological locations.
Owner:GANEDEN BIOTECH

Bacillus and application thereof

The invention discloses a bacillus and application thereof, and belongs to the field of biological control. A bacillus strain is bacillus methylotrophicus C1, and a preservation number of the bacillus strain is GDMCC No.60046. The application includes that the bacillus can be used as a biological control strain to be applied to antagonistic crop pathogenic bacteria; the bacillus can be used as a lipopeptide and / or protein fermentation strain for inhibiting crop pathogenic bacteria; the bacillus can be used as a growth promotion strain to be applied to promoting growth of crops; the bacillus can be used as a fermentation strain for auxin. The bacillus and the application have the advantages that the strain has broad-spectrum antibacterial activity; lipopeptide substances with effects of inhibiting fusarium graminearum cannot be generated, but proteins with effects of inhibiting the fusarium graminearum can be generated; effects of promoting growth of corn can be realized by the strain C1, the root lengths and the stalk lengths of the corn of experiment groups are 3.15 and 3.05 times the root lengths and the stalk lengths of contrast groups respectively as compared with contrast, the root, stalk and seed weights of the corn of the experiment groups are 5.02, 4.33 and 1.4 times the root, stalk and seed weights of the contrast groups, and only little auxin can be generated by the strain C1.
Owner:ANHUI RUIHU BIO FERTILIZER +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products